Company research / EVMN
Evommune, Inc. (EVMN)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Evommune, Inc. reported revenue of $13.00M. Revenue grew 85.7% from the prior annual period.
Key ratios (year ended 2025-12-31)
-623.6%
Operating margin
-529.8%
Net margin
-33.5%
Return on year-end equity
85.7%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.